id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2011-N-0655-0029,FDA,FDA-2011-N-0655,AGDUFA Public Meeting 05-20-2021 - Transcript,Other,Transcript(s),2021-06-29T04:00:00Z,2021,6,2021-06-29T04:00:00Z,,2021-06-29T15:27:37Z,,0,0,0900006484bbf71d
FDA-2011-N-0655-0028,FDA,FDA-2011-N-0655,AGDUFA Public Meeting 05-20-2021 - FDA Presentation,Other,Presentation,2021-06-29T04:00:00Z,2021,6,2021-06-29T04:00:00Z,,2021-06-29T15:26:10Z,,0,0,0900006484bbf71b
FDA-2011-N-0655-0027,FDA,FDA-2011-N-0655,Animal Generic Drug User Fee Act; Public Meeting; Request for Comments,Notice,Request for Comments,2021-04-12T04:00:00Z,2021,4,2021-04-12T04:00:00Z,2022-12-02T04:59:59Z,2022-12-02T02:00:24Z,2021-07375,0,0,0900006484aa3673
FDA-2011-N-0655-0026,FDA,FDA-2011-N-0655,Animal Generic Drug User Fee Act; Stakeholder Consultation Meetings on the Animal Generic Drug User Fee Act Reauthorization; Request for Notification of Stakeholder Intention To Participate,Notice,Notice of Intent,2021-04-12T04:00:00Z,2021,4,2021-04-12T04:00:00Z,2021-05-19T03:59:59Z,2021-04-12T13:47:34Z,2021-07374,0,0,0900006484aa3038